Table 5 Comparative analysis of tumor marker levels.

From: Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer

Tumor marker

Comparison

Experimental group (mean ± SD)

Control group (mean ± SD)

t

P

CEA

Before treatment

37.63 ± 2.68

37.03 ± 3.74

0.841

0.403

CEA

After treatment

20.30 ± 1.31

25.68 ± 2.21

13.412

0.0

CA125

Before treatment

57.70 ± 6.54

57.15 ± 6.29

0.387

0.7

CA125

After treatment

40.75 ± 2.21

46.53 ± 2.41

11.294

0.0

CYFRA21-1

Before treatment

15.57 ± 1.17

15.43 ± 1.17

0.516

0.607

CYFRA21-1

After treatment

10.15 ± 0.66

11.72 ± 0.80

9.672

0.0

Back to article page